Aspiriant LLC’s Schwab US Large- Cap ETF SCHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.98M | Sell |
194,382
-33,018
| -15% | -$886K | 0.14% | 70 |
|
|
2025
Q4 | $6.12M | Sell |
227,400
-2,519
| -1% | -$67.3K | 0.18% | 63 |
|
|
2025
Q3 | $6.06M | Sell |
229,919
-491
| -0.2% | -$12.5K | 0.19% | 57 |
|
|
2025
Q2 | $5.63M | Sell |
230,410
-1,352
| -0.6% | -$30.6K | 0.18% | 57 |
|
|
2025
Q1 | $5.12M | Sell |
231,762
-23,152
| -9% | -$539K | 0.18% | 55 |
|
|
2024
Q4 | $5.91M | Sell |
254,914
-2,072
| -0.8% | -$48.3K | 0.21% | 52 |
|
|
2024
Q3 | $5.81M | Buy |
256,986
+2,658
| +1% | +$57.9K | 0.22% | 50 |
|
|
2024
Q2 | $5.45M | Hold |
254,328
| – | – | 0.22% | 53 |
|
|
2024
Q1 | $5.26M | Sell |
254,328
-4,896
| -2% | -$96.4K | 0.22% | 55 |
|
|
2023
Q4 | $4.87M | Buy |
259,224
+1,719
| +0.7% | +$30.2K | 0.22% | 55 |
|
|
2023
Q3 | $4.34M | Buy |
257,505
+2,145
| +0.8% | +$37.6K | 0.22% | 56 |
|
|
2023
Q2 | $4.46M | Sell |
255,360
-8,631
| -3% | -$143K | 0.23% | 55 |
|
|
2023
Q1 | $4.26M | Buy |
263,991
+924
| +0.4% | +$14.5K | 0.22% | 55 |
|
|
2022
Q4 | $3.96M | Sell |
263,067
-13,329
| -5% | -$202K | 0.2% | 59 |
|
|
2022
Q3 | $3.9M | Sell |
276,396
-3,726
| -1% | -$58.5K | 0.19% | 54 |
|
|
2022
Q2 | $4.17M | Sell |
280,122
-4,941
| -2% | -$80.1K | 0.2% | 57 |
|
|
2022
Q1 | $5.12M | Sell |
285,063
-20,745
| -7% | -$367K | 0.28% | 49 |
|
|
2021
Q4 | $5.8M | Buy |
305,808
+36,948
| +14% | +$683K | 0.31% | 42 |
|
|
2021
Q3 | $4.66M | Sell |
268,860
-1,302
| -0.5% | -$23.2K | 0.27% | 46 |
|
|
2021
Q2 | $4.68M | Sell |
270,162
-12,576
| -4% | -$212K | 0.26% | 41 |
|
|
2021
Q1 | $4.52M | Sell |
282,738
-11,118
| -4% | -$174K | 0.29% | 36 |
|
|
2020
Q4 | $4.46M | Sell |
293,856
-402
| -0.1% | -$5.75K | 0.3% | 36 |
|
|
2020
Q3 | $3.95M | Sell |
294,258
-1,698
| -0.6% | -$22.6K | 0.31% | 41 |
|
|
2020
Q2 | $3.66M | Sell |
295,956
-76,278
| -20% | -$889K | 0.34% | 38 |
|
|
2020
Q1 | $3.8M | Sell |
372,234
-16,296
| -4% | -$198K | 0.37% | 37 |
|
|
2019
Q4 | $4.98M | Buy |
388,530
+17,892
| +5% | +$219K | 0.46% | 34 |
|
|
2019
Q3 | $4.38M | Buy |
370,638
+4,698
| +1% | +$55.4K | 0.39% | 41 |
|
|
2019
Q2 | $4.28M | Sell |
365,940
-37,566
| -9% | -$432K | 0.36% | 46 |
|
|
2019
Q1 | $4.55M | Sell |
403,506
-17,508
| -4% | -$190K | 0.37% | 47 |
|
|
2018
Q4 | $4.19M | Sell |
421,014
-10,830
| -3% | -$116K | 0.32% | 51 |
|
|
2018
Q3 | $5M | Sell |
431,844
-117,372
| -21% | -$1.33M | 0.43% | 44 |
|
|
2018
Q2 | $5.95M | Sell |
549,216
-59,868
| -10% | -$646K | 0.51% | 39 |
|
|
2018
Q1 | $6.4M | Buy |
609,084
+542,088
| +809% | +$5.9M | 0.56% | 36 |
|
|
2017
Q4 | $712K | Sell |
66,996
-860,562
| -93% | -$8.91M | 0.21% | 42 |
|
|
2017
Q3 | $9.28M | Sell |
927,558
-255,606
| -22% | -$2.51M | 0.78% | 29 |
|
|
2017
Q2 | $11.4M | Sell |
1,183,164
-117,918
| -9% | -$1.12M | 0.99% | 24 |
|
|
2017
Q1 | $12.2M | Sell |
1,301,082
-6,060
| -0.5% | -$56K | 1.04% | 24 |
|
|
2016
Q4 | $11.6M | Sell |
1,307,142
-1,488
| -0.1% | -$12.9K | 1.05% | 20 |
|
|
2016
Q3 | $11.3M | Buy |
1,308,630
+209,712
| +19% | +$1.8M | 1.12% | 16 |
|
|
2016
Q2 | $9.03M | Sell |
1,098,918
-406,356
| -27% | -$3.34M | 0.85% | 16 |
|
|
2016
Q1 | $12.3M | Buy |
+1,505,274
| New | +$11.6M | 1.17% | 14 |
|
|
2015
Q4 | – | Sell |
-30,900
| Closed | -$245K | – | 87 |
|
|
2015
Q3 | $245K | Buy |
30,900
+72
| +0.2% | +$582 | 0.02% | 94 |
|
|
2015
Q2 | $253K | Buy |
+30,828
| New | +$259K | 0.02% | 98 |
|
Other funds holding SCHX
HSA
MGIA
SFG
Aspiriant LLC's SCHX Position: Q1 2026 in Review
Aspiriant LLC reduced its Schwab US Large- Cap ETF (SCHX) stake by 15% in Q1 2026, selling an estimated $886K and leaving 194,382 shares worth $4.98M. The position accounts for 0.14% of the portfolio, ranked #70.
Aspiriant LLC first reported a position in SCHX in Q2 2015 and has held it in 43 quarters since. The position peaked at $12.3M in Q1 2016. 1,534 funds tracked by Wall St. Rank hold SCHX as of Q1 2026.
- Aspiriant LLC held 194,382 shares of Schwab US Large- Cap ETF worth $4.98M as of Q1 2026.
- Aspiriant LLC sold 33,018 Schwab US Large- Cap ETF shares in Q1 2026, an estimated $886K.
- Schwab US Large- Cap ETF made up 0.14% of Aspiriant LLC's portfolio in Q1 2026, its #70 holding.
- Aspiriant LLC first reported a position in Schwab US Large- Cap ETF in Q2 2015 and has held it in 43 quarters since.
- Aspiriant LLC's Schwab US Large- Cap ETF position peaked at $12.3M in Q1 2016.
- 1,534 funds tracked by Wall St. Rank held Schwab US Large- Cap ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.